id: limited_aud_pharmacotherapy_development_to_aud_recovery_optimization
name: Limited Development of New AUD Pharmacotherapies â†’ Optimization of AUD Recovery
  Goals
from_node:
  node_id: limited_aud_pharmacotherapy_development
  node_name: Limited Development of New AUD Pharmacotherapies
to_node:
  node_id: aud_recovery_optimization
  node_name: Optimization of AUD Recovery Goals
direction: negative
category: political
mechanism_pathway:
- 'Step 1: Limited investment in research and development of new AUD medications restricts
  available pharmacotherapy options'
- 'Step 2: Fewer medication options limits ability to match optimal treatments to
  diverse patient neurobiological profiles'
- 'Step 3: Patients with poor response to existing medications lack alternative pharmacological
  approaches'
- 'Step 4: Suboptimal medication matching reduces achievement of individualized recovery
  goals'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Barbara J Mason and Charles J Heyser 2021. "Alcohol Use Disorder:
    The Role of Medication in Recovery.." *Alcohol research : current reviews*. https://doi.org/10.35946/arcr.v41.1.07'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.677911'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: research_funding_allocation
  direction: strengthens
  strength: strong
  description: Increased public and private investment in AUD pharmacotherapy research
    would expand available treatment options
- name: regulatory_approval_pathways
  direction: strengthens
  strength: moderate
  description: Streamlined FDA approval processes for AUD medications could accelerate
    availability of new pharmacotherapies
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/political/limited_aud_pharmacotherapy_development_to_aud_recovery_optimization.yaml
_category: political
